This microRNA also manifests antiproliferative properties against hepatocellular carcinoma cells, concomitantly reducing cellular steatosis and fibrosis by targeting PPARα and TIMP2 [22]. This evidence concerns the gene PPARA and hepatocellular carcinoma.